Feds' Biotech Enforcement Efforts Are Too Heavy-Handed
A recent federal government settlement involving California-based biotech Ultragenyx is the latest example of how the U.S. Department of Justice's heavy-handed approach to enforcement of the federal Anti-Kickback Statute can punish...To view the full article, register now.
Already a subscriber? Click here to view full article